PD‐L1 expression in NSCLC: Role of cell blocks and concordance between samples
Sign Up to like & getrecommendations! Published in 2020 at "Diagnostic Cytopathology"
DOI: 10.1002/dc.24646
Abstract: PD‐L1 immunohistochemistry is currently performed in patients with advanced non‐small cell lung carcinoma (NSCLC) to identify responders to immune checkpoint inhibitors. Cell blocks from fine needle aspiration of NSCLC are frequently used for diagnostic purposes.… read more here.
Keywords: nsclc role; concordance; expression nsclc; cell ... See more keywords
Various impacts of driver mutations on the PD-L1 expression of NSCLC
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0273207
Abstract: We aimed to evaluate whether different driver mutations have varying impacts on the programmed cell death-ligand 1 (PD-L1) expression of non-small cell lung cancer (NSCLC), and whether the prognostic roles of PD-L1 amongst our patients… read more here.
Keywords: various impacts; strong positive; expression nsclc; mutant patients ... See more keywords
HuR, TTP, and miR-133b expression in NSCLC and their association with prognosis.
Sign Up to like & getrecommendations! Published in 2021 at "European review for medical and pharmacological sciences"
DOI: 10.26355/eurrev_202104_25521
Abstract: The article "HuR, TTP, and miR-133b expression in NSCLC and their association with prognosis, by L. Qian, A.-H. Ji, W.-J. Zhang, N. Zhao, published in Eur Rev Med Pharmacol Sci 2018; 22 (2): 430-442-DOI: 10.26355/eurrev_201801_14192-PMID:… read more here.
Keywords: ttp mir; mir 133b; expression nsclc; nsclc association ... See more keywords